The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration.
Journal Article (Journal Article;Review)
Precompetitive collaboration is a growing driver for innovation and increased productivity in biomedical science and drug development. The Biomarkers Consortium, a public-private platform for precompetitive collaboration specific to biomarkers, demonstrated that adiponectin has potential utility as a predictor of metabolic responses to peroxisome proliferator-activated receptor (PPAR) agonists in individuals with type 2 diabetes. Despite the challenges overcome by this project, the most important lesson learned is that cross-company precompetitive collaboration is a feasible robust approach to biomarker qualification.
- Wagner, JA; Prince, M; Wright, EC; Ennis, MM; Kochan, J; Nunez, DJR; Schneider, B; Wang, M-D; Chen, Y; Ghosh, S; Musser, BJ; Vassileva, MT
- May 2010
Volume / Issue
- 87 / 5
Start / End Page
- 539 - 542
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
- United States